<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Biotechnology - Newslocker]]></title><link>https://www.newslocker.com/en-us/profession/biotechnology/</link><atom:link rel="self" href="https://www.newslocker.com/en-us/profession/biotechnology/rss/" /><atom:link rel="hub" href="http://pubsubhubbub.appspot.com" /><description><![CDATA[Find your latest Biotechnology news with just one click. Don't miss out on anything happening in your profession!]]></description><language>en-us</language><copyright>Copyright (C) 2026 newslocker.com</copyright><lastBuildDate>Thu, 16 Jul 2026 18:38:00 +0200</lastBuildDate><item><title><![CDATA[Mary-Dell Chilton Dies at 87; Helped Create First Genetically Modified Plant]]></title><description><![CDATA[In 1982, she led the research team that figured out how to genetically alter plants, a discovery that would eventually transform global agriculture.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mary-dell-chilton-dies-at-87-helped-create-first-genetically-modified-plant/</link><pubDate>Thu, 16 Jul 2026 18:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mary-dell-chilton-dies-at-87-helped-create-first-genetically-modified-plant/</guid></item><item><title><![CDATA[Programmable mycolysins expand the antimicrobial toolkit against mycobacteria]]></title><description><![CDATA[In a timely advance for antimycobacterial biotechnology, Abouhmad et al. engineered modular ‘mycolysins’ that combine mycobacteriophage lysis functions with membrane-active peptides to efficiently breach the mycobacterial envelope and achieve pathogen intracellular killing. Their work opens a route that may accelerate the development of biologics against tuberculosis and nontuberculous mycobacterial diseases.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/programmable-mycolysins-expand-the-antimicrobial-toolkit-against-mycobacteria/</link><pubDate>Thu, 18 Jun 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/programmable-mycolysins-expand-the-antimicrobial-toolkit-against-mycobacteria/</guid></item><item><title><![CDATA[The New Race to Find Treatments for Measles]]></title><description><![CDATA[As vaccination rates decline, biotech companies see a potential new market for measles drugs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-new-race-to-find-treatments-for-measles/</link><pubDate>Wed, 17 Jun 2026 16:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-new-race-to-find-treatments-for-measles/</guid></item><item><title><![CDATA[With Measles Roaring Back, the Search for a Drug is On]]></title><description><![CDATA[As vaccination rates decline, biotech companies see a potential new market for measles drugs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/with-measles-roaring-back-the-search-for-a-drug-is-on/</link><pubDate>Thu, 11 Jun 2026 17:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/with-measles-roaring-back-the-search-for-a-drug-is-on/</guid></item><item><title><![CDATA[Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here]]></title><description><![CDATA[The biotech billionaire who wants to rebuild your body and blow your mind.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/better-sex-better-hair-better-sleep-humanmaxxing-is-here/</link><pubDate>Thu, 11 Jun 2026 11:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/better-sex-better-hair-better-sleep-humanmaxxing-is-here/</guid></item><item><title><![CDATA[As Ebola Spreads in East Africa, Will China Step Up?]]></title><description><![CDATA[China is well positioned to help stop the deadly virus, and could move into a gap left by U.S. retreat.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/as-ebola-spreads-in-east-africa-will-china-step-up/</link><pubDate>Sat, 06 Jun 2026 11:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/as-ebola-spreads-in-east-africa-will-china-step-up/</guid></item><item><title><![CDATA[China’s Rise in Drug Development Looms Over U.S.]]></title><description><![CDATA[Clinical trials in China are getting attention at an international oncology gathering in Chicago. China&rsquo;s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/chinas-rise-in-drug-development-looms-over-us/</link><pubDate>Sun, 31 May 2026 18:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/chinas-rise-in-drug-development-looms-over-us/</guid></item><item><title><![CDATA[Reprogramming halophilic life for low-salt biomanufacturing]]></title><description><![CDATA[By reengineering Halomonas bluephagenesis to grow and produce polyhydroxybutyrate under low-salinity, open conditions, Sun et al. transform salinity from a fixed physiological constraint into a bioprocess variable. This study reframes halophilic chassis design for more flexible and sustainable industrial biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-halophilic-life-for-low-salt-biomanufacturing/</link><pubDate>Sat, 16 May 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-halophilic-life-for-low-salt-biomanufacturing/</guid></item><item><title><![CDATA[Biotechnologies based on the fungal bioluminescence pathway]]></title><description><![CDATA[The originally published article contained figures that did not comply with the journal’s policies regarding the use of generative AI. Figures 1, 4, and 5 have been replaced, and the associated captions have been modified. The authors regret the error.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnologies-based-on-the-fungal-bioluminescence-pathway/</link><pubDate>Fri, 08 May 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnologies-based-on-the-fungal-bioluminescence-pathway/</guid></item><item><title><![CDATA[Blue at the edge]]></title><description><![CDATA[‘Blue at the Edge’ was created using C-phycocyanin (C-PC)-containing total soluble protein extract from extremophilic Galdieria. The painting portrays a moonlit desert, a quiet terrain that appears lifeless, but in a vibrant living blue made from algae. This visual contrasts the acidic, high-temperature environments where Galdieria thrives—inhospitable habitats that actually sustain metabolically versatile life. This alga thrives under elevated CO2 in complete darkness and very low pH on a]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/blue-at-the-edge/</link><pubDate>Thu, 07 May 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/blue-at-the-edge/</guid></item><item><title><![CDATA[The Rich and Powerful Want to Live Forever]]></title><description><![CDATA[From the Kremlin to Silicon Valley, some of the most powerful people in the world now want something more: eternal life.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-rich-and-powerful-want-to-live-forever/</link><pubDate>Fri, 24 Apr 2026 11:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-rich-and-powerful-want-to-live-forever/</guid></item><item><title><![CDATA[Scientific breakthrough versus successful startup: teaching scientists to navigate bench to business]]></title><description><![CDATA[Scientific breakthroughs infrequently translate into startups without structured training. Stanford’s BioEntrepreneurship Bootcamp teaches a practical framework for navigating bench-to-business translation. The curriculum integrates instruction on intellectual property, team formation, risk assessments, milestone-based funding, and investor communication, with the goal of equipping scientists to advance discoveries into viable ventures.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scientific-breakthrough-versus-successful-startup-teaching-scientists-to-navigate-bench-to-business/</link><pubDate>Wed, 08 Apr 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scientific-breakthrough-versus-successful-startup-teaching-scientists-to-navigate-bench-to-business/</guid></item><item><title><![CDATA[Engineered phage-derived lysins effectively kill mycobacterial pathogens]]></title><description><![CDATA[Treatment of mycobacterial infections is difficult due to poor penetration of antibiotics across the complex cell envelope. We engineered phage-inspired lytic proteins, mycolysins, that selectively breach this barrier and enable rapid bacterial clearance in pulmonary and wound infection models, highlighting a programmable biologic platform to enhance and shorten existing therapies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-phage-derived-lysins-effectively-kill-mycobacterial-pathogens/</link><pubDate>Mon, 30 Mar 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-phage-derived-lysins-effectively-kill-mycobacterial-pathogens/</guid></item><item><title><![CDATA[Clinical-scale bioreactor production of hiPSC-derived extracellular vesicles modulates miRNA and protein cargo to enhance angiogenic function]]></title><description><![CDATA[A perfusion-based stirred-tank bioreactor enables scalable production of human induced pluripotent stem cell–derived extracellular vesicles (EVs) enriched in proangiogenic cargo. This approach overcomes key limitations of conventional EV production, delivering high yields and consistent quality, and represents an important step toward standardized, clinically relevant EV manufacturing for cell-free regenerative therapies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/clinical-scale-bioreactor-production-of-hipsc-derived-extracellular-vesicles-modulates-mirna-and-protein-cargo-to-enhance-angiogenic-function/</link><pubDate>Mon, 30 Mar 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/clinical-scale-bioreactor-production-of-hipsc-derived-extracellular-vesicles-modulates-mirna-and-protein-cargo-to-enhance-angiogenic-function/</guid></item><item><title><![CDATA[Synthetic M13 phage engagers expand CAR-T cell antigen recognition to overcome tumor heterogeneity]]></title><description><![CDATA[This work reports a bacteriophage-based engager platform that simultaneously addresses antigen heterogeneity and functional exhaustion of chimeric antigen receptor T cells in solid tumors. It enables modular antigen redirection and eliminates immune suppression to improve antitumor responses.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/synthetic-m13-phage-engagers-expand-car-t-cell-antigen-recognition-to-overcome-tumor-heterogeneity/</link><pubDate>Fri, 27 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/synthetic-m13-phage-engagers-expand-car-t-cell-antigen-recognition-to-overcome-tumor-heterogeneity/</guid></item><item><title><![CDATA[How to Turn a Chicken Egg Into a Drug Factory]]></title><description><![CDATA[A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/how-to-turn-a-chicken-egg-into-a-drug-factory/</link><pubDate>Thu, 26 Mar 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/how-to-turn-a-chicken-egg-into-a-drug-factory/</guid></item><item><title><![CDATA[Utilizing biomolecular condensates as electrochemical reactors]]></title><description><![CDATA[Liquid–liquid phase separation and biomolecular condensates have received massive fundamental research interest in recent years. Yu et al. engineered self-assembling, genetically encoded biomaterials that function as electrochemical reactors. Their work demonstrates the great utility of these materials in nanoparticle synthesis, pollutant degradation, and inhibition of bacteria through artificial ferroptosis.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/utilizing-biomolecular-condensates-as-electrochemical-reactors/</link><pubDate>Wed, 25 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/utilizing-biomolecular-condensates-as-electrochemical-reactors/</guid></item><item><title><![CDATA[David Botstein, Gene-Mapping Pioneer, Dies at 83]]></title><description><![CDATA[His method of locating genes in human DNA allowed researchers to find disease-causing genes, and later to map the entire, sprawling human genome.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/david-botstein-gene-mapping-pioneer-dies-at-83/</link><pubDate>Fri, 20 Mar 2026 22:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/david-botstein-gene-mapping-pioneer-dies-at-83/</guid></item><item><title><![CDATA[Seamless vessel–microenvironment bioprinting reveals contact-dependent vascular communications]]></title><description><![CDATA[Current bioprinting often creates artificial barriers that disrupt cell communication. Zhao et al. introduce a seamless, collagen-based platform that eliminates material interfaces. This continuous microenvironment enables the discovery of critical contact-dependent signaling mechanisms in vascular development and cancer progression, offering a versatile tool for dissecting complex tissue interactions.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/seamless-vesselmicroenvironment-bioprinting-reveals-contact-dependent-vascular-communications/</link><pubDate>Wed, 18 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/seamless-vesselmicroenvironment-bioprinting-reveals-contact-dependent-vascular-communications/</guid></item><item><title><![CDATA[Breaking the immunosuppressive barrier: an armored CAR-M biotechnology with the original M1 phenotype dominance rescues antitumor immunity]]></title><description><![CDATA[The immunosuppressive environment of solid tumors limits the efficacy of current chimeric antigen receptor macrophage (CAR-M) therapies. We report a novel armored CAR-M technology that can dominate the tumor microenvironment and revitalize antitumor immunity. This breakthrough opens up promising new avenues for cancer immunotherapy, particularly for the treatment of solid tumors.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/breaking-the-immunosuppressive-barrier-an-armored-car-m-biotechnology-with-the-original-m1-phenotype-dominance-rescues-antitumor-immunity/</link><pubDate>Wed, 18 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/breaking-the-immunosuppressive-barrier-an-armored-car-m-biotechnology-with-the-original-m1-phenotype-dominance-rescues-antitumor-immunity/</guid></item></channel></rss>